Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Partial-Onset Seizures”

192 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 192 results

Large-scale testing (Phase 3)Study completedNCT01463306
What this trial is testing

A 12-Month Study To Evaluate The Safety And Tolerability Of Pregabalin As Add-On Therapy In Pediatric Subjects 1 Month To 16 Years Of Age With Partial Onset Seizures And Pediatric And Adult Subjects 5 To 65 Years Of Age With Primary Generalized Tonic-Clonic Seizures

Who this might be right for
Epilepsy, Partial SeizuresEpilepsy, Primary Generalized Tonic-Clonic Seizures
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 605
Large-scale testing (Phase 3)Study completedNCT00160615
What this trial is testing

Follow-up Study of L059 (Levetiracetam) in Epileptic Patients With Partial Onset Seizures by Open Label Method

Who this might be right for
Epilepsy, Partial
UCB Japan Co. Ltd. 154
Large-scale testing (Phase 3)Study completedNCT00520741
What this trial is testing

Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-onset Seizures

Who this might be right for
Epilepsy
UCB BIOSCIENCES, Inc. 426
Large-scale testing (Phase 3)Study completedNCT00368069
What this trial is testing

Look at the Efficacy and Safety of Keppra® Extended Release Formulation - XR

Who this might be right for
Epilepsy
UCB Pharma 158
Post-approval studies (Phase 4)Study completedNCT00713622
What this trial is testing

Comparing The Effect On Cognition Of Adjunctive Therapy With Zonisamide Versus Sodium Valproate

Who this might be right for
Epilepsy
Eisai Limited 2
Not applicableUnknownNCT05571371
What this trial is testing

Inflammatory Biomarkers in Psychogenic Non-epileptic Seizure

Who this might be right for
Localization-Related (Focal) (Partial) Idiopathic Epilepsy and Epileptic Syndromes With Seizures of Localized OnsetTRAIL: Tumor Necrosis Factor Related Apoptosis Inducing Ligand MCP-2MCP-2: Monocyte Chemo-attractant Protein-2
Esraa Mostafa Ahmed Abdel Aal 90
Testing effectiveness (Phase 2)Study completedNCT06377930
What this trial is testing

Study Evaluating the Safety and Efficacy of RAP-219 in Adult Participants With Refractory Focal Epilepsy

Who this might be right for
Focal Onset Seizures
Rapport Therapeutics Inc. 30
Post-approval studies (Phase 4)Study completedNCT01318408
What this trial is testing

Levetiracetam: The Anti-Convulsant of Choice for Elderly Patients With Dementia

Who this might be right for
Epilepsy
Drexel University College of Medicine 24
Testing effectiveness (Phase 2)Study completedNCT00236873
What this trial is testing

The Efficacy and Safety of Topiramate as add-on Therapy in the Treatment of Epilepsy Patients With Difficult to Treat, Partial-onset Seizures.

Who this might be right for
EpilepsyEpilepsies, PartialSeizures
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 47
Large-scale testing (Phase 3)Study completedNCT00464269
What this trial is testing

Double-blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures

Who this might be right for
Epilepsy
UCB Pharma 400
Post-approval studies (Phase 4)Study completedNCT01235403
What this trial is testing

Trial to Assess Optimized Dosage of Lacosamide as add-on Therapy in Patients With Partial Onset Seizure

Who this might be right for
Partial Epilepsies
UCB Pharma 100
Testing effectiveness (Phase 2)Ended earlyNCT04529954
What this trial is testing

Anti-Epilepsy Medication Valproate Administered Via ICV Route and Catheters and Pumps for CSF Infusion

Who this might be right for
Focal Epilepsy
Cerebral Therapeutics LLC 20
Testing effectiveness (Phase 2)Study completedNCT00610454
What this trial is testing

Safety and Tolerability of Levetiracetam Intravenous 15 Minute Infusion in Subjects Suffering From Partial Onset Seizures

Who this might be right for
Epilepsy
UCB Pharma 25
Testing effectiveness (Phase 2)Looking for participantsNCT07219407
What this trial is testing

A Long-term Study of the Safety and Effectiveness of RAP-219 in Adults With Focal Onset Seizures

Who this might be right for
Focal EpilepsyEpilepsyRefractory Focal Epilepsy+3 more
Rapport Therapeutics Inc. 30
Large-scale testing (Phase 3)Study completedNCT00367432
What this trial is testing

A Long Term Follow up Administration Study of L059 (Levetiracetam) in Epilepsy Patients With Partial Onset Seizures

Who this might be right for
EpilepsiesPartial
UCB Japan Co. Ltd. 398
Not applicableStudy completedNCT01620840
What this trial is testing

Lacosamid-i.v.-Register

Who this might be right for
Epilepsy With Partial Onset Seizures With or Without Secondary Generalization
University Hospital Schleswig-Holstein 130
Not applicableStudy completedNCT01281280
What this trial is testing

PuLsE 2-Observational Long-Term Effectiveness Follow-Up Study of PuLsE 1

Who this might be right for
Epilepsy
Cyberonics, Inc. 81
Not applicableNo Longer AvailableNCT03559673
What this trial is testing

Compassionate Use Program With Lacosamide in Patients With Partial-onset or Generalized Tonic-clonic Seizures

Who this might be right for
Epilepsies, Partial
UCB Biopharma S.P.R.L.
Not applicableUnknownNCT01978470
What this trial is testing

External Trigeminal Nerve Stimulation for Drug Resistent Epilepsy

Who this might be right for
Seizure Disorder
NeuroSigma, Inc. 20
Testing effectiveness (Phase 2)Study completedNCT00236691
What this trial is testing

The Efficacy and Safety of Topiramate as add-on Therapy in the Treatment of Epilepsy Patients With Difficult to Treat, Partial-onset Seizures.

Who this might be right for
EpilepsyEpilepsies, PartialSeizures
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 188
Load More Results